Business

EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

The European Medicines Agency didn’t specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly’s Mounjaro.

Previous post The Ratings Game: Netflix has been getting a lot of love lately. Could that spell trouble ahead of earnings?
Next post : Dow scores best day in a month, stocks post back-to-back gains as investors await inflation update

More Stories